...
首页> 外文期刊>International archives of allergy and immunology >World allergy organization anaphylaxis guidelines: 2013 update of the evidence base
【24h】

World allergy organization anaphylaxis guidelines: 2013 update of the evidence base

机译:世界过敏组织过敏反应指南:2013年证据基础更新

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis are a widely disseminated and used resource for information about anaphylaxis. They focus on patients at risk, triggers, clinical diagnosis, treatment in health care settings, self-treatment in the community, and prevention of recurrences. Their unique strengths include a global perspective informed by prior research on the global availability of essentials for anaphylaxis assessment and management and a global agenda for anaphylaxis research. Additionally, detailed colored illustrations are linked to key concepts in the text [Simons et al.: J Allergy Clin Immunol 2011;127:593.e1-e22]. The recommendations in the original WAO Anaphylaxis Guidelines for management of anaphylaxis in health care settings and community settings were based on evidence published in peer-reviewed, indexed medical journals to the end of 2010. These recommendations remain unchanged and clinically relevant. An update of the evidence base was published in 2012 [Simons et al.: Curr Opin Allergy Clin Immunol 2012;12:389-399]. In 2012 and early 2013, major advances were reported in the following areas: further characterization of patient phenotypes; development of in vitro tests (for some allergens) that help distinguish clinical risk of anaphylaxis from asymptomatic sensitization; epinephrine (adrenaline) research, including studies of a new epinephrine auto-injector for use in community settings, and randomized controlled trials of immunotherapy to prevent food-induced anaphylaxis. Despite these advances, the need for additional prospective studies, including randomized controlled trials of interventions in anaphylaxis is increasingly apparent. This 2013 Update highlights publications from 2012 and 2013 that further contribute to the evidence base for the recommendations made in the original WAO Anaphylaxis Guidelines. Ideally, it should be used in conjunction with these Guidelines and with the 2012 Guidelines Update.
机译:世界过敏组织(WAO)的过敏反应评估和管理指南是广泛传播和使用的有关过敏反应信息的资源。他们重点关注处于危险中的患者,触发因素,临床诊断,卫生保健机构中的治疗,社区中的自我治疗以及预防复发。他们的独特优势包括:从全球角度出发,根据先前对过敏反应评估和管理必需品的全球可用性的研究得出的结论,以及全球过敏反应研究的议程。另外,详细的彩色插图与文本中的关键概念相关联[Simons等人:J Allergy Clin Immunol 2011; 127:593.e1-e22]。最初的《 WAO过敏性指南》中有关在医疗机构和社区中进行过敏性反应管理的建议是基于截至2010年底在同行评审的索引医学期刊上发表的证据。这些建议保持不变且具有临床意义。证据基础的更新发表于2012年[Simons等人:Curr Opin Allergy Clin Immunol 2012; 12:389-399]。在2012年和2013年初,在以下领域报告了重大进展:患者表型的进一步表征; (有助于某些过敏原的)体外试验的发展,有助于将过敏反应的临床风险与无症状致敏区分开来;肾上腺素(肾上腺素)研究,包括在社区环境中使用的新型肾上腺素自动注射器的研究,以及预防食物引起的过敏反应的免疫疗法随机对照试验。尽管取得了这些进展,但对其他前瞻性研究的需求日益明显,包括对过敏反应干预措施的随机对照试验。此2013年更新重点介绍了2012年和2013年的出版物,这些出版物进一步为原始WAO过敏性指南中提出的建议提供了证据基础。理想情况下,应与这些准则以及2012年准则更新一起使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号